Any feedback?
Literature summary for 3.1.8.1 extracted from
- Polymorphisms of paraoxonase (PON1) and their significance in clinical toxicology of organophosphates (2003), J. Toxicol. Clin. Toxicol., 41, 37-45.
Application
| Application | Comment | Organism |
|---|---|---|
| medicine | relevance of enzyme polymorphism for modulating sensitivity to organometallic compounds | Homo sapiens |
Natural Substrates/ Products (Substrates)
| Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
|---|---|---|---|---|---|---|
| additional information | Homo sapiens | polymorphism of enzyme and implications | ? | - |
? |  |
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Homo sapiens | - |
polymorphism of enzyme | - |
Substrates and Products (Substrate)
| Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
|---|---|---|---|---|---|---|
| additional information | polymorphism of enzyme and implications | Homo sapiens | ? | - |
? | |
Subunits
| Subunits | Comment | Organism |
|---|---|---|
| More | polymorphism of enzyme | Homo sapiens |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
